CompletedNot Applicable

Validation of a Novel Non-invasive Continuous Blood Pressure Monitor in Children Ages 2- 17 Years-old

United States35 participantsStarted 2021-05-14

Plain-language summary

This is a prospective observational study to investigate if a non-invasive blood pressure monitoring device, the CareTaker Pulse Decomposition Analysis (PDA), can accurately measure blood pressure in children when compared to an arterial line. Enrolled patients will have the CareTaker PDA device placed on their finger during their operation to collect data for 30 minutes. Blood pressure readings from the CareTaker PDA device will be compared to measurements from the patient's indwelling arterial line, which will be placed as part of the patient's clinical care plan.

Who can participate

Age range2 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Plan to receive an invasive arterial blood pressure monitor as part of their anesthesia care plan at the BCH Longwood campus Exclusion Criteria: * Patients with vascular or congenital heart disease known to affect large and small arteries * Patients who declined to participate.

What they're measuring

Blood Pressure Comparison

Timeframe: One hour during procedure

Trial details

NCT IDNCT04817137

SponsorBoston Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-21

View on ClinicalTrials.gov More Blood Pressure trials